1 / 27

The Overlapping Neurobiology of Depression and Pain: WHAT CAN WE DO TO CHANGE THINGS?

The Overlapping Neurobiology of Depression and Pain: WHAT CAN WE DO TO CHANGE THINGS?. Rakesh Jain MD , MPH. Introduction: Four Things to Keep in Mind. ‘Abnormal’ psychological problems – such as anxiety and depression, are very common in pain conditions

kim
Télécharger la présentation

The Overlapping Neurobiology of Depression and Pain: WHAT CAN WE DO TO CHANGE THINGS?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Overlapping Neurobiology of Depression and Pain: WHAT CAN WE DO TO CHANGE THINGS? Rakesh Jain MD, MPH

  2. Introduction: Four Things to Keep in Mind • ‘Abnormal’ psychological problems – such as anxiety and depression, are very common in pain conditions • This creates a bi-directional, ‘spiral down’ negative impact on the pain patient • Multiple links exist between pain and psychological issues – neuro-endocrine, neuro-inflammation, autonomic disruptions, etc • Treatment – pain outcomes are negatively impacted if psychological issues are not well identified (thankfully, the reverse is equally true!)

  3. Is Pain Impacted by the Co-occurrence of Anxiety and/or Depression ? *p<0.001 * 8 Pain only (n=271) * * 7 * * * 6 Pain + Anxiety (n=15) 5 Brief Pain Inventory Pain Score (mean) range : 0-10 Pain + Depression (n=98) 4 3 Pain + Anxiety + Depression (n=116) 2 1 Pain Severity Pain Interference Bair MJ et.al. Psychosom Med 2008;70:890-7

  4. Chronic Pain after Accidental Injury & its Relationship to Anxiety / Depression (HADS-Depression and anxiety score) *p<0.05 * • 3 years later – 45% had chronic pain • 3 years after accident – 4.4% developed PTSD • 10%+ developed subsyndromal PTSD • all but one patient with PTSD (full or sub-syndromic) had chronic pain 5.4 * 4.6 3.1 2.0 Jenewein J et al. J Psychosom Res 2009;66:119-26

  5. Neck Pain and Anxiety – Increasing Pain Predicts Increasing Anxiety n=448*p<0.001 HADS Anxiety Sub-scale Mean Scores (s score range 0-21) HADS – Hospital Anxiety and Depression ScaleNPAD-d – Neck Pain and Disability Scale German Version Blozik E et al. BMC Musculoskel Dis 2009;10(13):1-8

  6. DPNP Patients – Relationship Between Pain and Mental Disorders n=255 *p<0.01 * * * Mean Score BPI – DPN Average Pain Severity HADS = Hospital Anxiety and Depression ScaleBPI = Brief Pain Inventory Gore M et al. J Pain Symptom Manage 2005;30(4):374-85

  7. Do Anxiety, Depression, or Sleep Problems Predict the Development of Pain? Odds ratio Odds ratio Depression(HAD Depression sub-score) Anxiety(HAD Anxiety sub-score) 15-month prospective study, 3171 followed, 324 developed chronic widespread pain Odds ratio Sleep(Sleep Problem Scale) Gupta A et.al. Rheumatology 2007;46:666-71

  8. The Pain Circuit Involves Sensory, Emotional, and Cognitive Regions of the Brain Somatosensory cortex Limbic system Cerebrum Thalamus Brainstem Slow, unmyelinated C-fibers Spinal cord Spinothalamic tract Dorsal ganglion Fast, myelinated A-fibers Afferent nerve fiber Adapted from Giordano J. Pain Physician 2005;8:277-90

  9. A Closer Look at Shared Anatomy: Complex Circuits Involve Sensory, Cognitive and Emotional Regions Apkarian AV et al. Eur J Pain 2005;9:463-84

  10. Primary nociceptive afferents (-) BRAINSTREAM MIDBRAIN (-) PSTT (-) (+) (+) (+) CORTICO- LIMBIC INPUT GABA INTER-NEURON SPINAL INTER-NEURON NRM 5-HT PAG OPIOIDS RMC NE (+) (-) (+) DLF Many Neurotransmitters are Shared by Pain and Anxiety (+) 5-HT=5-hydroxytryptamine; DLF=dorolateral funiculus; NRM=nucleus raphe mangus; RMC=reticular magnocellular nuclei; PAG=periaqueductal grey substance; PSTT=paleospinothalic tract. Giordano J. Pain Physician 2005;8:277-90

  11. Neuroendocrine and Neuroimmune Dysregulation in Pain Syndromes Red = inhibitory pathway Green = stimulatory pathway 1) Raison CL et al. Trends Immunol 2006;27:24-31. 2) Nestler EJ et al. Neuron 2002;34:13-25 3) Blackburn-Munro G et al. J Neuroendocrinol 2001;13:1009-23

  12. A Comprehensive, Neurobiological View of Pain and Psychology Jain R et al. Curr Diab Rep 2011;11:275–84

  13. Immunologic Impact of Pain With Increasing Duration of Pain Catecholamines, Neurokinin K Increased sympathetic activity Substance P IL-6 Sympathetic mediated pain IL-8 IL-IRa Hyperalgesia, fatigue, depression Serum IL-8 Serum IL-Ra Serum IL-6 * 764.9 *p<0.05 556.25 pg/mL * 37.08 18.45 7.1 • IL-8 is a proinflammatory cytokine, and mediates sympathetic pain • IL-Ra is involved with stress • IL-6 is involved with stress, fatigue, hyperalgesia, depression, and it activates sympathetic pain 7.3 <2-yr symptoms n=23 >2-yr symptoms n=23 Patients met ACR criteria for FM. Wallace DJ et al. Rheumatology 2001:40:743-9 Schwartz YA et al. Am J Resp Cell Mol Biol 1999;21:388-94

  14. Autonomic Dysregulationmay Augment Pain Norepinephrine-evoked pain 100 10 94.3 P<.05 9 80.0 P<.05 8 80 7 6 P =NS 60 5 54.3 54.3 56.3% P≤0.05 Patients (%) Visual analog scale (norepinephrine-placebo) 4 3 40 P =NS 30.0 30.0 2 1 20 0 11.9% -1 11.9% 16/20 6/20 6/20 0 -2 FM RA HC FM RA HC n=20 n=20 n=20 n=20 n=20 n=20 Martinez-Lavin M et al. BMC MusculoskeletDisord 2002;3:2

  15. Back Pain: Gray Matter Atrophy in Areas involved with Cognition and Emotional Regulation Patients with chronic back pain (CBP) had 5-11% less whole brain gray matter, equivalent to 10-20 years of normal aging ApkarianAV et.al. J Neurosci2004;24(46):10410-5

  16. In Pain Patients - Brain Perfusion Studies Implicate Anxiety Regulatory Centers Bilateral parietal perfusion (BA7) Bilateral post-central perfusion (BA4) Left anterior temporal perfusion Negative correlation Positive correlation GuedjE et al. J Nucl Med 2008;49;11:1798-803

  17. Grey Matter Loss in Pain – in Regions also Involved With Anxiety Regulation *p<0.001 * Volume (mm3) * Patients with FM (n=10) had significantly less GM volume in posterior cingulate, insular cortex, MFC, and parahippocampalgyrus. Rate of age-related decline was significantly greater in patients with FM than in controls (n=10; p<0.001) Patients with FM were losing 10.5 cm3 of gray matter/year since their diagnosis MFC=medical frontal cortex. Kuchinad A et al. J Neurosci 2007;27:4004-7

  18. A Suggested Clinical Pathway to Managing Anxiety/Depression in a Patient with Pain Routinely screen for anxiety D/Os Optimize treatment of pain Use scales / screeners Non-pharmacological treatment/s Pharmacological treatment/s If anxiety still persists

  19. Scales for Diagnosing Anxiety Disorders Hamilton Anxiety Scale (HAM-A) Beck Anxiety Inventory (BAI) Hospital Anxiety and Depression Scale (HADS)

  20. A Clinically Useful Anxiety Screener – GAD-7 KroenkeK et al. Ann Intern Med 2007;146:317-25

  21. GAD-7 – Useful for Detecting Multiple Anxiety Disorders GAD-7 Score of ≥8 Generalizedanxiety D/O Panic D/O Socialanxiety D/O PTSD KroenkeK et al. Ann Intern Med 2007;146:317-25

  22. Pharmacological Treatment Options for Anxiety Disorders

  23. Mind-Body Intervention for Older Adults with Chronic Pain Change from Baseline Scores CES-D STAI BPI - Interference Berman RLH et al. J Pain 2009;10(1):68-79

  24. Cognitive Behavioral Management of Chronic Pain * • Six weekly 90 minute group sessions • Based on CBT attention management manual * *p<0.05 * * * * Average pain (0-10 scale) n=18 Pain-related anxiety(Pass-20) n=20 (n=41; data for individuals completing 6-month follow-up) Elomaa MM et al. Eur J Pain. 2009; 13(10):1062-7

  25. Multidisciplinary Treatment: Impact on Improvement and HPA Changes 3 weeks of multidisciplinary treatment consisting of education, stretching, CBT, relaxation training, and aerobic exercise Before admission and treatment Before treatment After treatment 69 64.1 63.1 * 57.3 48.9 * p <.05 * 38 24.9 * 22.4 13.5 13.3 13.3 * 5.5 Positive VAS % of Pain CES-D Tender Score Area Score Points N=12. CBT=cognitive behavioral therapy; CES-D=Center for Epidemologic Studies Depression Rating Scale. Bonifazi M et al. Psychoneuroendocrinology2006;31:1076-86

  26. Anxiety, Stress, Neuroendocrine, and Immune Dysfunction as Potential Pain Mediators Genetic predisposition Poor sleep ANS dysfunction Psychological factors, stress Trauma Neuroendocrine- immune dysfunction Infections, Inflammation Neonatal, Childhood trauma Hyperexcitement of central neurons Environmental, Chemical Other factors Central sensitization Other mechanisms Central sensitization Central sensitivity syndromes Yunus MB. Semin Arthritis Rheum 2007;36:339-56

  27. In Conclusion – Emerging Data Reveal Pain has sensory, emotional, and cognitive components Although not all patients with pain disorders have comorbid mood disorders, they are present in a substantial number of patients Emerging data reveal a strong Bio – Psycho – Social interactional model between pain and anxiety / depression Clinical decisions in patients with overlapping pain and anxiety / depression should focus on amelioration of both conditions

More Related